Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Peter Lammer investment portfolio
Peter Lammer has made numerous investments in companies such as Accession Therapeutics within the Biotech sector.
Portfolio
1
Team
0
Shareholding changes (3)
Peter Lammer's positions across portfolio companies2025
- ORDINARY 37,790 → 90,116
- A SHARES 0 → 25,000
2024
- ORDINARY 11,627 → 37,790
Articles (1)
- Accession Therapeutics secures £5.7m to advance targeted cancer immunotherapies26 Mar 2026Accession Therapeutics